参考文献/References:
[1] 罗梦佳,戴艳然,郎红娟.消化道肿瘤患者术中低体温预测模型构建与验证[J].空军军医大学学报,2023,44(9):885-889.
[2] 布力布?吉力斯汉,赛福丁?柯尤木,刘春晖,等.长链非编码RNA核富集转录子1对胃癌SGC7901细胞迁移、侵袭、自噬的影响及机制研究[J].陕西医学杂志,2023,52(12):1749-1753.
[3] 韩少静,郭永泽,郑扬,等.内镜下胃癌活检组织中组织蛋白酶D和人类表皮生长因子受体2表达及意义[J].陕西医学杂志,2023,52(9):1249-1253.
[4] 沈家林,许雨晴,曹若彤,等.金果胃康胶囊对胃癌前病变模型大鼠胃黏膜ULK1/AMPK/mTOR信号通路的影响[J].陕西中医,2024,45(4):446-450.
[5] 朱晶,王琦苑,钱蓉,等.消痰散结方联合卡培他滨治疗晚期胃癌临床研究[J].陕西中医,2024,45(2):191-195.
[6] 王源媛,周妮,王达,等.生物标志物EHD3与胃癌中免疫细胞浸润的相关性研究[J].西安交通大学学报(医学版),2023,44(3):374-382.
[7] RANDOLPH K,HYDER U,D'ORSO I.KAP1/TRIM28:Transcriptional activator and/or repressor of viral and cellular programs?[J].Frontiers in Cellular and Infection Microbiology,2022,12(1):834636.
[8] CZERWI-SKA P,MAZUREK S,WIZNEROWICZ M.The complexity of TRIM28 contribution to cancer[J].Journal of Biomedical Science,2017,24(1):63.
[9] HUANG N,SUN X,LI P,et al.TRIM family contribute to tumorigenesis,cancer development,and drug resistance[J].Experimental Hematology & Oncology,2022,11(1):75.
[10] ZHANG W,CAI Z,KONG M,et al.Prognostic significance of TRIM28 expression in patients with breast carcinoma[J].Open Medicine,2021,16(1):472-480.
[11] LIU J,HAN X,CHEN L,et al.TRIM28 is a distinct prognostic biomarker that worsens the tumor immune microenvironment in lung adenocarcinoma[J].Aging(Albany NY),2020,12(20):20308.
[12] ZHOU S,PENG J,XIAO L,et al.TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability[J].Cell Death & Disease,2021,12(5):463.
[13] 胡玲,王英,蒋斌元,等.硼替佐米联合PLK1抑制剂处理肿瘤细胞A549、HeLa对其增殖影响[J].中国药理学通报,2023,39(11):2115-2121.
[14] 雷艳花.硼替佐米为主的化疗方案治疗新发多发性骨髓瘤的效果[J].吉林医学,2023,44(10):2899-2902.
[15] YANG L,CHEN J,HAN X,et al.Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway[J].Protein & Cell,2018,9(9):770-784.
[16] ZHENG Z,FAN S,ZHENG J,et al.Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma[J].Journal of Hematology & Oncology,2018,11(1):29.
[17] ALLMEROTH K,HORN M,KROEF V,et al.Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma[J].Leukemia,2021,35(3):887-892.
[18] 赫捷,陈万青,李兆申,等.中国胃癌筛查与早诊早治指南(2022,北京)[J].中国肿瘤,2022,31(7):488-527.
[19] CHANG J,HWANG H J,KIM B,et al.TRIM28 functions as a negative regulator of aggresome formation[J].Autophagy,2021,17(12):4231-4248.
[20] YANG Y,TAN S,HAN Y,et al.The role of tripartite motif-containing 28 in cancer progression and its therapeutic potentials[J].Frontiers in Oncology,2023,13(1):1100134.
[21] ZHOU W,CHEN H,RUAN Y,et al.High expression of TRIM15 is associated with tumor invasion and predicts poor prognosis in patients with gastric cancer[J].Journal of Investigative Surgery,2021,34(8):853-861.
[22] KONG F,MA L,WANG X,et al.Regulation of epithelial-mesenchymal transition by protein lysine acetylation[J].Cell Communication and Signaling,2022,20(1):1-14.
[23] HERQUEL B,OUARARHNI K,DAVIDSON I.The TIF1α-related TRIM cofactors couple chromatin modifications to transcriptional regulation,signaling and tumor suppression[J].Transcription,2011,2(5):231-236.
[24] NING T,ZHAO M,ZHANG N,et al.TRIM28 suppresses cancer stem-like characteristics in gastric cancer cells through Wnt/β-catenin signaling pathways[J].Experimental Biology and Medicine,2023,248(23):2210-2218.
[25] NENASHEVA V V,TARANTUL V Z.Many faces of TRIM proteins on the road from pluripotency to neurogenesis[J].Stem Cells and Development,2020,29(1):1-14.
[26] PAULETTO E,EICKHOFF N,PADRÃO N A,et al.TRIMming down hormone-driven cancers:The biological impact of TRIM proteins on tumor development,progression and prognostication[J].Cells,2021,10(6):1517.
[27] LIU J,ZHAO R,JIANG X,et al.Progress on the application of bortezomib and bortezomib-based nanoformulations[J].Biomolecules,2021,12(1):51.
[28] ZOU Q,LIU M,LIU K,et al.E3 ubiquitin ligases in cancer stem cells:Key regulators of cancer hallmarks and novel therapeutic opportunities[J].Cellular Oncology,2023,46(3):545-570.
[29] HAN D,WANG L,JIANG S,et al.The ubiquitin proteasome system in breast cancer[J].Trends in Molecular Medicine,2023,29(8):599-621.
相似文献/References:
[1]侯洁心 ,郭萍△.免疫组化标志物Her2和肿瘤标志物在胃癌诊断中的价值分析*[J].陕西医学杂志,2019,(1):121.
HOU Jiexin,GUO Ping..The value of immunohistochemical marker Her2 andtumor markers in the diagnosis of gastric cancer[J].,2019,(9):121.
[2]唐亚荣.循环热灌注化疗联合替吉奥及热疗治疗老年胃癌癌性腹水临床研究*[J].陕西医学杂志,2019,(4):435.
TANG Yarong..Clinical effect analysis of combined therapy with tiago and hyperthermia in the treatment of malignant ascites in elderly patients with gastric cancer[J].,2019,(9):435.
[3]刘国庆,闫 龙△,高 任.1.5T磁共振扩散加权成像在胃癌淋巴结转移诊断中的应用价值*[J].陕西医学杂志,2019,(4):456.
LIU Guoqing,YAN Long,GAO Ren..1.5T magnetic resonance diffusion weighted imaging in the diagnosis of lymph node metastasis of gastric cancer[J].,2019,(9):456.
[4]胡乃军,王海龙.胃腺癌组织中MMP11、MMP12和VEGFD的表达及临床意义[J].陕西医学杂志,2019,(5):554.
[5]米志宽,赵菊梅.抑癌基因甲基化与胃癌关系研究进展*[J].陕西医学杂志,2019,(5):679.
MI Zhikuan,ZHAO Jumei..Research progress of relationships between tumor suppressor gene methylation and gastric cancer[J].,2019,(9):679.
[6]石颖鹏,王敏娟,李程亮.肠化生相关分子与胃癌的发生和进展研究概况[J].陕西医学杂志,2019,(7):958.
SHI Yingpeng,WANG Minjuan,LI Chengliang,et al.Intestinal metaplasia-related molecules and the occurrence and progress of gastric cancer[J].,2019,(9):958.
[7]郭小艳,于桂萍.抗幽门螺杆菌疗法联合新辅助化疗对胃癌术后疗效及患者血清VEGF、bFGF的影响[J].陕西医学杂志,2019,(8):1010.
GUO Xiaoyan,YU Guiping..Effect of anti-Helicobacter pylori therapy combined with neoadjuvant chemotherapy on serum VEGF and bFGF in postoperative patients with gastric cancer[J].,2019,(9):1010.
[8]柯东平,毛俊倩,郭甲民,等.SCNN1B与胃癌细胞上皮间质转化相关性实验研究*[J].陕西医学杂志,2019,(9):1115.
KE Dongping,MAO Junqian,GUO Jiamin,et al.Research on the correlation between SCNN1B and〖JZ〗 epithelialmesenchymal transformation in gastric cancer cells[J].,2019,(9):1115.
[9]王小林,马任远,张 哲.腹腔镜手术治疗老年进展期胃癌50例临床疗效分析[J].陕西医学杂志,2019,(10):1360.
[10]刘维帅,郭晓宁,杨 洋,等.胃癌病理类型及临床预后与血清miR-133a和DKK-1相关性分析[J].陕西医学杂志,2020,49(6):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]
LIU Weishuai,GUO Xiaoning,YANG Yang,et al.Correlation of pathological types and clinical prognosis of gastric cancer with serum miR-133a and DKK-1[J].,2020,49(9):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]